Copyright © 2008 I. Rektorova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. R. Marconi, D. Lefebvre-Caparros, A.-M. Bonnet, M. Vidailhet, B. Dubois, and Y. Agid, “Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology,” Movement Disorders, vol. 9, no. 1, pp. 2–12, 1994. View at Publisher · View at Google Scholar · View at PubMed
2. O. Rascol, U. Sabatini, and C. Brefel, et al., “Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia,” Brain, vol. 121, no. 3, pp. 527–533, 1998. View at Publisher · View at Google Scholar
3. O. Rascol, D. J. Brooks, A. D. Korczyn, P. P. De Deyn, C. E. Clarke, and A. E. Lang, “A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa,” The New England Journal of Medicine, vol. 342, no. 20, pp. 1484–1491, 2000. View at Publisher · View at Google Scholar · View at PubMed
4. G. Koch, L. Brusa, and C. Caltagirone, et al., “rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease,” Neurology, vol. 65, no. 4, pp. 623–625, 2005. View at Publisher · View at Google Scholar · View at PubMed
5. P. Piccini, R. A. Weeks, and D. J. Brooks, “Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias,” Annals of Neurology, vol. 42, no. 5, pp. 720–726, 1997. View at Publisher · View at Google Scholar · View at PubMed
6. E. Bezard, J. M. Brotchie, and C. E. Gross, “Pathophysiology of levodopa-induced dyskinesia: potential for new therapies,” Nature Reviews Neuroscience, vol. 2, no. 8, pp. 577–588, 2001. View at Publisher · View at Google Scholar · View at PubMed
7. J. A. Obeso, M. C. Rodriguez-Oroz, M. Rodriguez, M. R. DeLong, and C. W. Olanow, “Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model,” Annals of Neurology, vol. 47, no. 4, supplement 1, pp. S22–S34, 2000.
8. A. M. Lozano, A. E. Lang, R. Levy, W. Hutchison, and J. Dostrovsky, “Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine,” Annals of Neurology, vol. 47, no. 4, supplement 1, pp. S141–S146, 2000.
9. D. J. Brooks, P. Piccini, N. Turjanski, and M. Samuel, “Neuroimaging of dyskinesia,” Annals of Neurology, vol. 47, no. 4, supplement 1, pp. S154–S158, 2000.
10. H. R. Siebner and J. Rothwell, “Transcranial magnetic stimulation: new insights into representational cortical plasticity,” Experimental Brain Research, vol. 148, no. 1, pp. 1–16, 2003. View at Publisher · View at Google Scholar · View at PubMed
11. A. Pascual-Leone, J. Valls-Solé, J. P. Brasil-Neto, A. Cammarota, J. Grafman, and M. Hallett, “Akinesia in Parkinson's disease. II. Effects of subthreshold repetitive transcranial motor cortex stimulation,” Neurology, vol. 44, no. 5, pp. 892–898, 1994.
12. R. Cantello, R. Tarletti, and C. Civardi, “Transcranial magnetic stimulation and Parkinson's disease,” Brain Research Reviews, vol. 38, no. 3, pp. 309–327, 2002. View at Publisher · View at Google Scholar
13. J.-P. Lefaucheur, “Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation,” Clinical Neurophysiology, vol. 116, no. 2, pp. 244–253, 2005. View at Publisher · View at Google Scholar · View at PubMed
14. M. P. Lomarev, S. Kanchana, W. Bara-Jimenez, M. Iyer, E. M. Wassermann, and M. Hallett, “Placebo-controlled study of rTMS for the treatment of Parkinson's disease,” Movement Disorders, vol. 21, no. 3, pp. 325–331, 2006. View at Publisher · View at Google Scholar · View at PubMed
15. A. P. Strafella, J. H. Ko, and O. Monchi, “Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation,” NeuroImage, vol. 31, no. 4, pp. 1666–1672, 2006. View at Publisher · View at Google Scholar · View at PubMed
16. L. Brusa, V. Versace, and G. Koch, et al., “Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease,” Clinical Neurophysiology, vol. 117, no. 9, pp. 1917–1921, 2006. View at Publisher · View at Google Scholar · View at PubMed
17. A. Wagle-Shukla, M. J. Angel, and C. Zadikoff, et al., “Low-frequency repetitive transcranial magnetic stimulation for treatment of levodopa-induced dyskinesias,” Neurology, vol. 68, no. 9, pp. 704–705, 2007. View at Publisher · View at Google Scholar · View at PubMed
18. I. Rektorova, S. Sedlackova, S. Telecka, A. Hlubocky, and I. Rektor, “Repetitive transcranial stimulation for freezing of gait in Parkinson's disease,” Movement Disorders, vol. 22, no. 10, pp. 1518–1519, 2007. View at Publisher · View at Google Scholar · View at PubMed
19. A. P. Strafella, T. Paus, M. Fraraccio, and A. Dagher, “Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex,” Brain, vol. 126, no. 12, pp. 2609–2615, 2003. View at Publisher · View at Google Scholar · View at PubMed
20. A. P. Strafella, T. Paus, J. Barrett, and A. Dagher, “Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus,” Journal of Neuroscience, vol. 21, no. 15, p. RC157, 2001.
21. W. R. G. Gibb and A. J. Lees, “The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 51, no. 6, pp. 745–752, 1988.
22. A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, “Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases,” Journal of Neurology Neurosurgery and Psychiatry, vol. 55, no. 3, pp. 181–184, 1992.
23. M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression and mortality,” Neurology, vol. 17, no. 5, pp. 427–442, 1967.
24. M. F. Folstein, S. E. Folstein, and P. R. McHugh, ““Mini mental state” a practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Publisher · View at Google Scholar
25. S. A. Montgomery and M. A. Asberg, “A new depression scale designed to be sensitive to change,” The British Journal of Psychiatry, vol. 134, pp. 382–389, 1979.
26. M. S. George, E. M. Wassermann, and T. A. Kimbrell, et al., “Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial,” American Journal of Psychiatry, vol. 154, no. 12, pp. 1752–1756, 1997.
27. M. Petrides and D. N. Pandya, “Dorsolateral prefrontal cortex: comparative cytoarchitectonic analysis in the human and the macaque brain and corticocortical connection patterns,” European Journal of Neuroscience, vol. 11, no. 3, pp. 1011–1036, 1999. View at Publisher · View at Google Scholar
28. S. Fahn and R. L. Elston, “Unified Parkinson's disease rating sscale,” in Recent Developments in Parkinson's Disease, S. Fahn, C. D. Marsden, M. Goldstein, and D. B. Calne, Eds., vol. 2, pp. 153–163, Macmillan, New York, NY, USA, 1987.
29. M. C. Ridding, R. Inzelberg, and J. C. Rothwell, “Changes in excitability of motor cortical circuitry patients with Parkinson's disease,” Annals of Neurology, vol. 37, no. 2, pp. 181–188, 1995. View at Publisher · View at Google Scholar · View at PubMed
30. M. Bareš, P. Kaňovský, H. Klajblová, and I. Rektor, “Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study,” European Journal of Neurology, vol. 10, no. 4, pp. 385–389, 2003. View at Publisher · View at Google Scholar
31. P. B. Fitzgerald, S. Fountain, and Z. J. Daskalakis, “A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition,” Clinical Neurophysiology, vol. 117, no. 12, pp. 2584–2596, 2006. View at Publisher · View at Google Scholar · View at PubMed
32. J. D. Rollnik, M. Schubert, and R. Dengler, “Subthreshold prefrontal repetitive transcranial magnetic stimulation reduces motor cortex excitability,” Muscle and Nerve, vol. 23, no. 1, pp. 112–114, 2000. View at Publisher · View at Google Scholar
33. K. Sakai, O. Hikosaka, S. Miyauchi, R. Takino, Y. Sasaki, and B. Pütz, “Transition of brain activation from frontal to parietal areas in visuomotor sequence learning,” Journal of Neuroscience, vol. 18, no. 5, pp. 1827–1840, 1998.
34. B. Haslinger, K. Kalteis, H. Boecker, F. Alesch, and A. O. Ceballos-Baumann, “Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease,” NeuroImage, vol. 28, no. 3, pp. 598–606, 2005. View at Publisher · View at Google Scholar · View at PubMed
35. U. Sabatini, K. Boulanouar, and N. Fabre, et al., “Cortical motor reorganization in akinetic patients with Parkinson's disease. a functional MRI study,” Brain, vol. 123, no. 2, pp. 394–403, 2000. View at Publisher · View at Google Scholar
36. R. Chen, R. R. Garg, A. M. Lozano, and A. E. Lang, “Effects of internal globus pallidus stimulation on motor cortex excitability,” Neurology, vol. 56, no. 6, pp. 716–723, 2001.
37. N. Modugno, A. Curra, F. Gilio, C. Lorenzano, S. Bagnato, and A. Berardeli, “Transcranial magnetic stimulation in movement disordes,” in Magnetic Stimulation in Clinical Neurophysiology, M. Hallett and S. Chokroverty, Eds., pp. 181–191, Elsevier, Philadelphia, Pa, USA, 2nd edition, 2005.
38. P. Payoux, P. Remy, and P. Damier, et al., “Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease,” Archives of Neurology, vol. 61, no. 8, pp. 1307–1313, 2004. View at Publisher · View at Google Scholar · View at PubMed
39. C. G. Goetz, W. Poewe, O. Rascol, and C. Sampaio, “Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004,” Movement Disorders, vol. 20, no. 5, pp. 523–539, 2005. View at Publisher · View at Google Scholar · View at PubMed
40. D. Knoch, V. Treyer, M. Regard, R. M. Müri, A. Buck, and B. Weber, “Lateralized and frequency-dependent effects of prefrontal rTMS on regional cerebral blood flow,” NeuroImage, vol. 31, no. 2, pp. 641–648, 2006. View at Publisher · View at Google Scholar · View at PubMed
41. M. Jahanshahi, I. H. Jenkins, R. G. Brown, C. D. Marsden, R. E. Passingham, and D. J. Brooks, “Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects,” Brain, vol. 118, no. 4, pp. 913–933, 1995. View at Publisher · View at Google Scholar
42. E. D. Playford, I. H. Jenkins, R. E. Passingham, J. Nutt, R. S. J. Frackowiak, and D. J. Brooks, “Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study,” Annals of Neurology, vol. 32, no. 2, pp. 151–161, 1992. View at Publisher · View at Google Scholar · View at PubMed
43. C. Haegelen, M. Verin, and B. A. Broche, et al., “Does subthalamic nucleus stimulation affect the frontal limbic areas? A single-photon emission computed tomography study using a manual anatomical segmentation method,” Surgical and Radiologic Anatomy, vol. 27, no. 5, pp. 389–394, 2005. View at Publisher · View at Google Scholar · View at PubMed
44. M. Samuel, A. O. Ceballos-Baumann, and N. Turjanski, et al., “Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an ${\text{H}}_2{}^{15}\text{O}$ PET study,” Brain, vol. 120, no. 8, pp. 1301–1313, 1997. View at Publisher · View at Google Scholar
45. S. Thobois, S. Guillouet, and E. Broussolle, “Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease,” Neurophysiologie Clinique, vol. 31, no. 5, pp. 321–340, 2001. View at Publisher · View at Google Scholar
46. J. F. Bates and P. S. Goldman-Rakic, “Prefrontal connections of medial motor areas in the rhesus monkey,” Journal of Comparative Neurology, vol. 336, no. 2, pp. 211–228, 1993. View at Publisher · View at Google Scholar · View at PubMed
47. P. Limousin, J. Greene, P. Pollak, J. Rothwell, A.-L. Benabid, and R. Frackowiak, “Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease,” Annals of Neurology, vol. 42, no. 3, pp. 283–291, 1997. View at Publisher · View at Google Scholar · View at PubMed
48. D. Eidelberg, J. R. Moeller, and T. Ishikawa, et al., “Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease,” Annals of Neurology, vol. 39, no. 4, pp. 450–459, 1996. View at Publisher · View at Google Scholar · View at PubMed
49. I. H. Jenkins, W. Fernandez, and E. D. Playford, et al., “Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine,” Annals of Neurology, vol. 32, no. 6, pp. 749–757, 1992. View at Publisher · View at Google Scholar · View at PubMed
50. A. M. Lozano, A. E. Lang, and N. Galvez-Jimenez, et al., “Effect of GPi pallidotomy on motor function in Parkinson's disease,” The Lancet, vol. 346, no. 8987, pp. 1383–1387, 1995. View at Publisher · View at Google Scholar
51. R. Katzenschlager, A. Hughes, and A. Evans, et al., “Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges,” Movement Disorders, vol. 20, no. 2, pp. 151–157, 2005. View at Publisher · View at Google Scholar · View at PubMed